Difficulty: Medium
Average Score: 63%
Practice
Which of the following drugs is least likely to be used as part of a controlled ovarian hyperstimulation protocol?
Correct answer
D
Rationale
In the context of controlled ovarian hyperstimulation protocols, the drug least likely to be used is Pergolide (Option D). Pergolide is a dopamine agonist primarily used in the management of Parkinson's disease and has limited to no role in ovarian stimulation protocols.
Human chorionic gonadotropin (Option A) is commonly used to trigger ovulation in assisted reproductive technologies. Leuprolide (Option B) is a GnRH agonist that can help prevent premature ovulation during ovarian stimulation. Menotropins (Option C) are a combination of FSH and LH hormones used to stimulate follicle development in the ovaries.
Educationally, understanding the specific roles of different drugs in controlled ovarian hyperstimulation is crucial for healthcare professionals working in reproductive endocrinology and infertility. By knowing which drugs are commonly used and their mechanisms of action, practitioners can optimize treatment protocols for patients undergoing fertility treatments.
Human chorionic gonadotropin (Option A) is commonly used to trigger ovulation in assisted reproductive technologies. Leuprolide (Option B) is a GnRH agonist that can help prevent premature ovulation during ovarian stimulation. Menotropins (Option C) are a combination of FSH and LH hormones used to stimulate follicle development in the ovaries.
Educationally, understanding the specific roles of different drugs in controlled ovarian hyperstimulation is crucial for healthcare professionals working in reproductive endocrinology and infertility. By knowing which drugs are commonly used and their mechanisms of action, practitioners can optimize treatment protocols for patients undergoing fertility treatments.